Research map: Safety, biodistribution, and exploratory clinical outcomes of a novel intra-articular IL-1Ra gene therapy (PCRX-201) in moderate-to-severe knee osteoarthritis: 2-year results of a phase 1 study

Back to the article

Papers in this map

  1. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee · Roy Davis Altman · 1986 · 6845 citations · Cited by this paper
  2. Industry updates in advanced therapy medicinal products and regenerative medicine – August 2026 · Duško Ilić · 2026 · Cites this paper
  3. Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment · 2026 · Related
  4. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis · Raveendhara R. Bannuru · 2019 · 3694 citations · Cited by this paper
  5. Response to correspondence on ‘Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life’ · 2026 · Related
  6. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis · Mohit Kapoor · 2010 · 2809 citations · Cited by this paper
  7. Mitochondrial-impaired ductal epithelium fuels TLS formation in Sjögren’s disease · 2026 · Related
  8. Classifications in Brief: Kellgren-Lawrence Classification of Osteoarthritis · Mark D. Kohn · 2016 · 1463 citations · Cited by this paper
  9. Development and validation of quality indicators for lupus nephritis, based on the 2025 EULAR recommendations: adherence trends and impact on clinical outcomes · 2026 · Related
  10. Synovitis in osteoarthritis: current understanding with therapeutic implications · Alexander Mathiessen · 2017 · 1106 citations · Cited by this paper
  11. Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis · 2026 · Related
  12. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. · T Pham · 2004 · 868 citations · Cited by this paper
  13. Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries · 2026 · Related
  14. Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study · Xavier Chevalier · 2009 · 537 citations · Cited by this paper
  15. Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma · 2026 · Related
  16. The Interleukin 1β Pathway in the Pathogenesis of Osteoarthritis · Massoud Daheshia · 2008 · 433 citations · Cited by this paper
  17. Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project · 2026 · Related
  18. Chondroprotective effect of intraarticular injections of interleukin‐1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase‐1 expression · John P. Caron · 1996 · 369 citations · Cited by this paper
  19. Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series · 2026 · Related
  20. Gutless adenovirus: last-generation adenovirus for gene therapy · R Alba · 2005 · 301 citations · Cited by this paper
  21. Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus · 2026 · Related
  22. In Vivo Transfer of Interleukin-1 Receptor Antagonist Gene in Osteoarthritic Rabbit Knee Joints · Julio Fernandes · 1999 · 219 citations · Cited by this paper
  23. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date · Win Min Oo · 2021 · 212 citations · Cited by this paper
  24. Proteoglycan 4 Expression Protects Against the Development of Osteoarthritis · Merry Z. C. Ruan · 2013 · 199 citations · Cited by this paper
  25. Joint space narrowing and Kellgren–Lawrence progression in knee osteoarthritis: an analytic literature synthesis · P.S. Emrani · 2008 · 191 citations · Cited by this paper
  26. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial · Jerry R. Mendell · 2024 · 179 citations · Cited by this paper
  27. Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement · Matthias Schieker · 2020 · 174 citations · Cited by this paper
  28. Osteoarthritis gene therapy · Christopher H. Evans · 2004 · 148 citations · Cited by this paper
  29. Pseudoseptic Reactions to Hylan Viscosupplementation · Victor M. Goldberg · 2004 · 143 citations · Cited by this paper
  30. Interleukin-1?-converting enzyme/caspase-1 in human osteoarthritic tissues: Localization and role in the maturation of interleukin-1? and interleukin-18 · Nathalie Saha · 1999 · 138 citations · Cited by this paper
  31. Gene Delivery to Joints by Intra-Articular Injection · Christopher H. Evans · 2017 · 134 citations · Cited by this paper
  32. Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations · Jerry R. Mendell · 2022 · 125 citations · Cited by this paper
  33. Recent advances in targeted drug delivery for treatment of osteoarthritis · Shikhar Mehta · 2020 · 105 citations · Cited by this paper
  34. Knee osteoarthritis: disease burden, available treatments, and emerging options · Michael J. Langworthy · 2024 · 102 citations · Cited by this paper
  35. Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy · Sergey S. Seregin · 2009 · 96 citations · Cited by this paper
  36. Disease‐Modifying Osteoarthritis Treatment With Interleukin‐1 Receptor Antagonist Gene Therapy in Small and Large Animal Models · Alan J. Nixon · 2018 · 85 citations · Cited by this paper
  37. Osteoarthritis: Current Molecular Biomarkers and the Way Forward · Virginia B. Kraus · 2020 · 62 citations · Cited by this paper
  38. What is new in pain modification in osteoarthritis? · Rachel E. Miller · 2017 · 59 citations · Cited by this paper
  39. Disease modification in osteoarthritis; pathways to drug approval · Jeffrey Neil Katz · 2020 · 49 citations · Cited by this paper

Source: OpenAlex (CC0)